Reckitt Benckiser Group (OTCMKTS:RBGLY) Raised to “Buy” at HSBC

HSBC upgraded shares of Reckitt Benckiser Group (OTCMKTS:RBGLYFree Report) from a hold rating to a buy rating in a report published on Wednesday, Marketbeat.com reports.

Several other research analysts have also weighed in on the stock. Sanford C. Bernstein lowered shares of Reckitt Benckiser Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, November 4th. UBS Group upgraded shares of Reckitt Benckiser Group to a “strong-buy” rating in a research note on Wednesday, September 18th. Citigroup upgraded shares of Reckitt Benckiser Group to a “strong-buy” rating in a research note on Tuesday, October 1st. JPMorgan Chase & Co. lowered shares of Reckitt Benckiser Group from an “overweight” rating to a “neutral” rating in a research note on Thursday, August 29th. Finally, Barclays raised shares of Reckitt Benckiser Group to a “strong-buy” rating in a report on Friday, October 4th. Three research analysts have rated the stock with a hold rating, one has issued a buy rating and four have assigned a strong buy rating to the company’s stock. According to MarketBeat, Reckitt Benckiser Group has a consensus rating of “Buy”.

Read Our Latest Analysis on RBGLY

Reckitt Benckiser Group Trading Up 0.2 %

Reckitt Benckiser Group stock opened at $12.26 on Wednesday. The company has a current ratio of 0.69, a quick ratio of 0.47 and a debt-to-equity ratio of 0.97. The firm’s 50 day moving average price is $12.33 and its two-hundred day moving average price is $11.73. Reckitt Benckiser Group has a twelve month low of $10.24 and a twelve month high of $15.03.

About Reckitt Benckiser Group

(Get Free Report)

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.

Read More

Analyst Recommendations for Reckitt Benckiser Group (OTCMKTS:RBGLY)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.